What are Prescription Drug Affordability Boards?

Though it sounds great, the ways in which Prescription Drug Affordability Boards are operating have negative implications for patients, funding of 340B programs, pharmacies, and the safety of the supply chain.

PSM's Shabbir Imber Safdar and CANN CEO Jen Laws go in depth to talk about what PDABs are, how the tools they have create unintended consequences, and what dangerous situations they are likely to create.